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Tissues are complex milieus consisting of numerous cell types. Several recent methods have attempted to enumerate
cell subsets from transcriptomes. However, the available methods have used limited sources for training and give only
a partial portrayal of the full cellular landscape. Here we present xCell, a novel gene signature-based method, and use it
to infer 64 immune and stromal cell types. We harmonized 1822 pure human cell type transcriptomes from various
sources and employed a curve fitting approach for linear comparison of cell types and introduced a novel spillover
compensation technique for separating them. Using extensive in silico analyses and comparison to cytometry
immunophenotyping, we show that xCell outperforms other methods. xCell is available at http://xCell.ucsf.edu/.Background
In addition to malignant proliferating cells, tumors are
also composed of numerous distinct non-cancerous cell
types and activation states of those cell types. Together
these are termed the tumor microenvironment, which
has been in the research spotlight in recent years and is
being further explored by novel techniques. The most
studied set of non-cancerous cell types are the tumor-
infiltrating lymphocytes (TILs). However, TILs are only
part of a variety of innate and adaptive immune cells,
stromal cells, and many other cell types that are found
in the tumor and interact with the malignant cells. This
complex and dynamic microenvironment is now recog-
nized to be important both in promoting and inhibiting
tumor growth, invasion, and metastasis [1, 2]. Under-
standing the cellular heterogeneity composing the tumor
microenvironment is key for improving existing treat-
ments, the discovery of predictive biomarkers, and
development of novel therapeutic strategies.
Traditional approaches for dissecting the cellular het-
erogeneity in liquid tissues are difficult to apply in solid
tumors [3]. Therefore, in the past decade, several
methods have been published for digitally dissecting the
tumor microenvironment using gene expression profiles
[4–7] (reviewed in [8]). Recently, a multitude of studies
have been published applying published and novel* Correspondence: dvir.aran@ucsf.edu; atul.butte@ucsf.edu
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such as The Cancer Genome Atlas (TCGA) [6, 9–13].
Two general types of techniques are used: deconvolving
the complete cellular composition and assessing enrich-
ments of individual cell types.
At least seven major issues raise concerns that the in
silico methods could be prone to errors and cannot
reliably portray the cellular heterogeneity of the tumor
microenvironment. First, current techniques depend on
the expression profiles of purified cell types to identify
reference genes and therefore rely heavily on the data
source from which the references are inferred and could
this be inclined to overfit these data. Second, current
methods focus on only a very narrow range of the tumor
microenvironment, usually a subset of immune cell
types, and thus do not account for the further richness
of cell types in the microenvironment, including blood
vessels and other different forms of cell subsets [14, 15].
A third problem is the ability of cancer cells to “imitate”
other cell types by expressing immune-specific genes,
such as a macrophage-like expression pattern in tumors
with parainflammation [16]; only a few of the methods
take this into account. Fourth, the ability of existing
methods to estimate cell abundance has not yet been
comprehensively validated in mixed samples. Cytometry
is a common method for counting cell types in a
mixture and, when performed in combination with gene
expression profiling, can allow validation of the estima-
tions. However, in most studies that included cytometry
validation, these analyses were performed on only a veryle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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samples [7, 13].
A fifth challenge is that deconvolution approaches are
prone to many different biases because of the strict de-
pendencies among all cell types that are inferred. This
could highly affect reliability when analyzing tumor
samples, which are prone to form non-conventional ex-
pression profiles. A sixth problem comes with inferring
an increasing number of closely related cell types [10].
Finally, deconvolution analysis heavily relies on the
structure of the reference matrix, which limits its appli-
cation to the resource used to develop the matrix. One
such deconvolution approach is CIBESORT, the most
comprehensive study to date, which allows the enumer-
ation of 22 immune subsets [7]. Newman et al. [7] per-
formed adequate evaluation across data sources and
validated the estimations using cytometry immunophe-
notyping. However, the shortcomings of deconvolution
approaches are apparent in CIBERSORT, which is
limited to Affymetrix microarray studies.
On the other hand, gene set enrichment analysis
(GSEA) is a simple technique which can be easily ap-
plied across data types and can be quickly applied for
cancer studies. In GSEA each gene signature is used
independently of all other signatures and it is thus pro-
tected from the limitations of deconvolution approaches.
However, because of this independence, it is many times
hard to differentiate between closely related cell types.
In addition, gene signature-based methods only provide
enrichment scores and thus do not allow comparison
across cell types and cannot provide insights into the
abundance of cell types in the mixture.
Here, we present xCell, a novel method that integrates
the advantages of gene set enrichment with deconvolution
approaches. We present a compendium of newly gener-
ated gene signatures for 64 cell types, spanning multiple
adaptive and innate immunity cells, hematopoietic
progenitors, epithelial cells, and extracellular matrix cells
derived from thousands of expression profiles. Using in
silico mixtures, we transform the enrichment scores to a
linear scale, and using a spillover compensation technique
we reduce dependencies between closely related cell types.
We evaluate these adjusted scores in RNA-seq and micro-
array data from primary cell type samples from various
independent sources. We examine their ability to digitally
dissect the tumor microenvironment by in silico analyses,
and perform the most comprehensive comparison to date
with cytometry immunophenotyping. We compare our in-
ferences with available methods and show that scores
from xCell are more reliable for digital dissection of mixed
tissues. Finally, we apply our method on TCGA tumor
samples to portray a full tumor microenvironment land-
scape across thousands of samples. We provide these esti-
mations to the community and hope that this resourcewill allow researchers to gain a better perspective of the
complex cellular heterogeneity in tumor tissues.
Results
Generating a gene signature compendium of cell types
To generate our compendium of gene signatures for cell
types, we collected gene expression profiles from six
sources: the FANTOM5 project, from which we anno-
tated 719 samples from 39 cell types analyzed by the
Cap Analysis Gene Expression (CAGE) technique [17];
the ENCODE project, from which we annotated 115
samples from 17 cell types analyzed by RNA-seq [18];
the Blueprint project, from which we annotated 144
samples from 28 cell types analyzed by RNA-seq [19];
the IRIS project, from which we annotated 95 samples
from 13 cell types analyzed by Affymetrix microarrays
[20]; the Novershtern et al. [21] study, from which we
annotated 180 samples from 24 cell types analyzed by
Affymetrix microarrays; and the Human Primary Cells
Atlas (HPCA), a collection of Affymetrix microarrays
composed of many different Gene Expression Omnibus
(GEO) datasets, from which we annotated 569 samples
from 41 cell types [22] (Fig. 1a). Altogether we collected
and curated gene expression profiles from 1822 samples
of pure cell types, annotated to 64 distinct cell types and
cell subsets (Fig. 1b; Additional file 1). Of those, 54 cell
types were found in at least two of these data sources. For
cell types with five or more samples in a data source, we
left one sample out for testing. All together, 97 samples
were left out, and all of the model training described
below was performed on the remaining 1725 samples.
Our strategy for selecting reliable cell type gene signa-
tures is shown in Fig. 1c (see Additional file 2: Figure S1
and “Methods” for a full description and technical
details). For each data source independently we identi-
fied genes that are overexpressed in one cell type com-
pared to all other cell types. We applied different
thresholds for choosing sets of genes to represent the
cell type gene signatures; hence, from each source, we
generated dozens of signatures per cell type. This
scheme yielded 6573 gene signatures corresponding to
64 cell types. Importantly, since our primary aim is to
develop a tool for studying the cellular heterogeneity in
the tumor microenvironment, we applied a methodology
we previously developed [16] to filter out genes that tend
to be overexpressed in a set of 634 carcinoma cell lines
from the Cancer Cell Line Encyclopedia (CCLE) [23].
Next, we used single-sample GSEA (ssGSEA) to score
each sample based on all signatures. ssGSEA is a well-
known method for determining a single, aggregate score
of the enrichment of a set of genes in the top of a
ranked gene expression profile [24]. To choose the most
reliable signatures we tested their performance in identi-
fying the corresponding cell type in each of the data
ab
c
Fig. 1 (See legend on next page.)
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Fig. 1 xCell study design. a A summary of the data sources used in the study to generate the gene signatures, showing the number of pure cell
types and number of samples curated from them. b Our compendium of 64 human cell type gene signatures grouped into five cell type families.
c The xCell pipeline. Using the data sources and based on different thresholds, we derived gene signatures for 64 cell types. Of this collection of
6573 signatures, we chose the 489 most reliable cell types, three for each cell type from each data source where available. The raw score is then
the average single-sample GSEA (ssGSEA) score of all signatures corresponding to the cell type. Using simulations of gene expression for each cell
type, we derived a function to transform the non-linear association between the scores to a linear scale. Using the simulations we also derive the
dependencies between cell type scores and apply a spillover compensation method to adjust the scores
Aran et al. Genome Biology  (2017) 18:220 Page 4 of 14sources. To prevent overfitting, each signature learned
from one data source was tested in other sources, but not
in the data source from which it was originally inferred.
To reduce biases resulting from a small number of genes
and from the analysis of different platforms, instead of
one signature per cell type, the top three ranked signatures
from each data source were chosen. Altogether we gener-
ated 489 gene signatures corresponding to 64 cell types
spanning multiple adaptive and innate immunity cells,
hematopoietic progenitors, epithelial cells, and extracellu-
lar matrix cells (Additional file 3). Observing the scores in
the 97 test primary cell type samples affirmed their ability
to identify the corresponding cell type compared to other
cell types across data sources (Additional file 2: Figure S2).
We defined the raw enrichment score per cell type to be
the average ssGSEA score from all the cell types’ corre-
sponding signatures.
Spillover compensation between closely related cell types
Our primary objective is to accurately identify enrich-
ment of cell types in mixtures. To imitate such ad-
mixtures, we performed an array of simulations of
gene expression combinations for different cell types
to assess the accuracy and sensitivity of our gene sig-
natures. We generated such in silico expression pro-
files using different data sources and different sets of
cell types in mixtures and by choosing randomly one
sample per cell type from all available samples in the
data source. The simulations revealed that our raw
scores reliably predict even small changes in the pro-
portions of cell types, distinguish between most cell
types, and are reliable in different transcriptomic ana-
lysis platforms (Additional file 2: Figure S3). However,
the simulations also revealed that raw scores of RNA-
seq samples are not linearly associated with the abun-
dance and that they do not allow comparisons across
cell types (Additional file 2: Figure S4). Thus, using the
training samples we generated synthetic expression pro-
files by mixing the cell type of interest with other, non-
related cell types. We then fit a formula that transforms
the raw scores to cell type abundances. We found that the
transformed scores showed resemblance to the known
fractions of the cell types in simulations, thus enabling
comparison of scores across cell types, and not just across
samples (Additional file 2: Figure S5).The simulations also revealed another limitation of the
raw scores: closely related cell types tend to have correl-
ating scores (Additional file 2: Figure S5). That is, scores
may show enrichment for a cell type due to a “spillover
effect” between closely related cell types. This problem
mimics the spillover problem in flow cytometry, in
which fluorescent signals correlate with each other due
to spectrum overlaps. Inspired by the compensation
method used in flow cytometry studies [25], we lever-
aged our simulations to generate a spillover matrix that
allows correcting for correlations between cell types. To
better compensate for low abundances in mixtures, we
created a simulated dataset where each sample contains
25% of the cell type of interest with the rest from a non-
related cell type and produced a spillover matrix, a
representation of the dependencies of scores between
different cell types.
Applying the spillover correction procedure on the
pure cell types (Fig. 2a) and simulated expression pro-
files (Fig. 2b, c; Additional file 2: Figures S5 and S6)
showed that this method was able to successfully reduce
associations between closely related cell types. For ex-
ample, we generated simulated mixtures using an inde-
pendent data source of multiple cell types that was not
used for the development of the method (GSE60424)
[26], and used our method to infer the underlying
abundances. We observed decent performance in recap-
itulating the cell type distributions. However, before cor-
recting for spillovers, there were false associations
between CD4+ and CD8+ T cells, as well as between
monocytes and neutrophils. The spillover correction was
able to reduce these associations significantly without
harming the correlations on the diagonal (Fig. 2b). In
addition, we generated simulated mixtures using the train-
ing samples (Additional file 2: Figure S5) and the test
samples (Additional file 2: Figure S6). In the 18 simu-
lated mixtures using the test samples, we observed an
overall average decrease of 17.1% in significant correla-
tions off the diagonal (Fig. 2c; Additional file 2: Figure S5).
Unexpectedly, following the spillover compensation we
observed slightly improved associations on the diagonal
between the scores and the underlying abundances (1.4%
average improvement).
Finally, many of the cell types we estimate are not ex-
pected to be in a given mixture; however, the pipeline
ab
c
Fig. 2 (See legend on next page.)
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Fig. 2 Evaluation of the performance of xCell using simulated mixtures. a An overview of adjusted scores for 43 cell types in 259 purified cell
type samples from the Blueprint and ENCODE data sources (other data sources are in Additional file 2: Figure S4). Most signatures clearly
distinguish the corresponding cell type from all other cell types. b A simulation analysis using GSE60424 as the data source [26], which was not
used in the development of xCell. This data source contains 114 RNA-seq samples from six major immune cell types. Left: Pearson correlation
coefficients using our method before spillover adjustment and after the adjustment. Dependencies between CD4+ T cells, CD8+ T cells, and NK
cells were greatly reduced; spillover from monocytes to neutrophils was also removed. Right: Comparison of the correlation coefficients across
the different methods. The first column corresponds to xCell’s predictions of the underlying abundances of the cell types in the simulations
(both color and pie chart correspond to average Pearson coefficients). Bindea, Charoentong, Palmer, Rooney, and Tirosh represent sets of signatures for
cell types from the corresponding manuscripts. Newman refers to the inferences produced using CIBERSORT on the simulations. xCell outperformed the
other methods in 17 of 18 comparisons. c Comparison of the correlation coefficients across the different methods based on 18 simulations generated
using the left-out testing samples. Here rows correspond to methods and columns show the average Pearson coefficient for the corresponding cell
type across the simulations. Independent simulations are available in Additional file 2: Figure S6. xCell outperformed the other methods in 64 of
67 comparisons
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18 test simulated mixtures, 56.4% of the scores for cell
types that are not part of the mixture were non-
negligible (> 0.001). To overcome this inadequacy, we
introduce a statistical significance test of whether a pro-
duced enrichment score is not random—whether the
cell type of interest is in the mixture. Using the reference
training data sets, for each cell type we generated ran-
dom mixtures of all cell types except the corresponding
cell type, and calculated the cell type-adjusted scores.
We then fit a beta distribution for each of the cell types
and used these distributions to calculate the probability
that the score of the corresponding cell type is present
in the mixture by random (Additional file 2: Figure S7).
Applying this procedure to the test simulated mixtures en-
abled detection of about half of the non-expected non-
negligible scores as non-significant (46.9% change—from
56.4% non-negligible scores to 28.8% with p value > 0.2),
while detecting as non-significant only 15.3% of non-
negligible scores for cell types used for generating the
mixture (from 88.6% non-negligible scores to 75.1%)
(Additional file 4).
This pipeline for generating adjusted cell type enrich-
ment scores from gene expression profiles, which we
named xCell, is available as an R package and a simple
web tool (http://xCell.ucsf.edu/).
Validation of enrichment scores in simulated expression
profiles
We next compared the ability of xCell scores to infer the
underlying cell type enrichments in simulated mixtures
with a set of 53 previously published signatures corre-
sponding to 26 cell types [6, 12, 27, 28] (Additional file 5).
Our analyses showed that xCell outperformed the previ-
ously published signatures in recapitulating the underlying
abundances, in mixtures generated using the training sam-
ples (Additional file 2: Figure S5) and the test samples
(Additional file 2: Figure S6) and an independent data
source (GSE60424 [26]) (Fig. 2b), in the vast majority of
the comparable cell types (51 of 53 comparisons ofmixtures generated using training samples, 46 of 49 using
test samples, and 17 of 18 using GSE60424) (Fig. 2c). xCell
showed overall better performance with all data sources
used, proving its versatility across platforms. Importantly,
our compensation technique was able to completely re-
move associations between cell types, while previously
published signatures showed considerate dependencies
between closely related cell types, such as between CD8+
T cells and NK cells (Additional file 2: Figure S8).
In addition, we also compared xCell’s performance on
test mixtures with that of CIBERSORT, a prominent
deconvolution-based method [7]. Unlike signature-based
methods, which output independent enrichment scores
per cell type, the output from deconvolution-based
methods is the inferred proportions of the cell types in
the mixture. Similar to the performance comparisons
using signatures, xCell also outperformed CIBERSORT
in all comparable cell types, across all data sources
(Fig. 2b, c; Additional file 2: Figures S5 and S6).
Validation of enrichment scores with cytometry
immunoprofiling
In addition to the simulated mixture analysis, we com-
pared our estimates for cell type enrichments from gene
expression profiles with mass spectrometry (CyTOF)
immunophenotyping. We utilized independent publicly
available studies in which a total of 165 individuals were
studied for both gene expression from whole blood and
FACS across 18 cell subsets from peripheral blood
mononuclear cells (PBMCs; available from ImmPort,
studies SDY311 and SDY420) [29]. We calculated xCell
scores for each of the signatures using the studies’ ex-
pression profiles and correlated the scores with the
FACS fractions of the cell subsets. Of the 14 cell types
with at least 1% abundance, xCell was able to signifi-
cantly recover 10 and 12 cell subsets in SDY311 and
SDY420, respectively (Pearson correlation between cal-
culated and actual cell counts p value < 0.05; Fig. 3).
Comparing the performance of xCell to previously
published signatures and CIBERSORT revealed that no
Fig. 3 Comparison of digital dissection methods with flow cytometry counts. Left: Scatter plots of CyTOF fractions in PBMCs vs. cell type scores
from whole blood of 61 samples from SDY311 (top) and 104 samples from SDY420 (bottom). Only the top correlating cell types in each study are
shown. Right: Correlation coefficients produced by our method compared to other methods. Only cell types with abundance of at least 1% on
average, as measured by CyTOF, are shown. Non-significant correlations (p value < 0.05) are marked with a gray “x”
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method was not able to recover in both data sets (Fig. 3).
In general, previous methods were able to recover signal
only from major cell types, including B cells, CD4+ and
CD8+ T cells, and monocytes, suggesting that their per-
formance was not reliable in more specialized cell sub-
sets. While our method also struggled in these cell
subsets, it still showed significant correlations with most
of the cell subsets, including effector memory CD8+ T
cells, naïve CD4+ T cells, and naïve B cells. In addition,
xCell was more reliable in CD4+ T cells and monocytes
and equally reliable in B cells (Fig. 3). In CD8+ T cells
xCell was outperformed by methods depending solely on
CD8A expression, which may not serve as a reliable bio-
marker in cancer settings (Additional file 2: Figure S9).
Despite the generally improved ability of xCell to esti-
mate cell populations, we do note that in some cases the
correlations we observed were relatively low, emphasiz-
ing the difficulty of estimating cell subsets in mixed sam-
ples, and the need for cautious examination and further
validation of findings.
Cell type enrichment in tumor samples
We next applied our methodology to 9947 primary tumor
samples across 37 cancer types from the TCGA andTARGET projects [30] (Additional file 2: Figure S10).
Average scores of cell types in each cancer type affirmed
prior knowledge of expected enriched cell types, validating
the power of our method for identifying the cell type of
origin of different cancer types. For example, epithelial
cells were enriched in carcinomas, keratinocytes in
squamous cell carcinomas, mesangial cells in kidney can-
cers, chondrocytes in sarcoma, neurons in brain tumors,
hepatocytes in hepatocellular carcinoma, melanocytes in
melanomas, B cells in B-cell lymphoma, T cells in
thymoma, myeloid cells in acute myeloid leukemia, and
lymphocytes in acute lymphocytic leukemia (Fig. 4a).
While these results are expected, it is reassuring that xCell
can be applied to human cancers.
Most of the cell types we infer are part of the com-
plex cellular heterogeneity of the tumor microenviron-
ment. We hypothesized that an additive combination of
all cell types’ scores would be negatively correlated with
tumor purity. Thus, we generated a microenvironment
score as the sum of all immune and stromal cell types.
We then correlated this microenvironment score with
our previously generated purity estimations, which are
based on copy number variations, gene expression,
DNA methylation, and H&E slides [31]. Our analysis
showed highly significant negative correlations in all
ab
Fig. 4 Cell type enrichment analysis in tumors. a Average scores for nine cell types across 24 cancer types from TCGA (The Cancger Genome
Atlas). Scores were normalized across rows. Signatures were chosen such that they are the cell of origin of a cancer type or the most significant
signature of the cancer type compared to all others. b t-SNE (t-Distributed Stochastic Neighbor Embedding) plot of 8875 primary cancer samples from
TCGA (The Cancger Genome Atlas) and TARGET colored by cancer type. The t-SNE plot was generated using the enrichment scores of 48
non-epithelial, non-stem cell, and non-cell type-specific scores. Many of the cancer types create distinct clusters, emphasizing the important role of
the tumor microenvironment in characterizing tumors
Aran et al. Genome Biology  (2017) 18:220 Page 8 of 14cancer types, suggesting this score as a novel mea-
surement for tumor microenvironment abundance
(Additional file 2: Figure S11).Finally, to provide insight into the potential of xCell to
portray the tumor microenvironment, we plotted all tumor
samples based on their cell type scores. Using different sets
Aran et al. Genome Biology  (2017) 18:220 Page 9 of 14of cell type inferences, we applied the t-Distributed
Stochastic Neighbor Embedding (t-SNE) dimensionality
reduction technique [32] (Additional file 2: Figure S12).
Interestingly, the analysis revealed that unique microenvir-
onment compositions characterize different cancer indica-
tions. For example, prostate cancers form a unique cluster
based on their immune cell type composition, while head
and neck tumors are distinguished by their stromal com-
position. Remarkably, only when performing the analysis
with all immune and stromal cell types did clear clusters
form distinguishing between most of the cancer types
(Fig. 4b), demonstrating the unique composition of the
tumor microenvironment, which differs between cancer
types. This notion emphasizes the importance of portraying
the full cellular heterogeneity of the tumor microenviron-
ment for the study of cancer. To this end, we calculated the
enrichment scores for 64 cell types across the TCGA
spectrum, and provide these data with the hope that they
will serve the research community as a resource to further
explore novel associations of cell type enrichment in hu-
man tumors (Additional file 6).Discussion
Recently, many studies have shown different methodologies
for the digital dissection of cancer samples [3, 6, 9–13].
These studies have provided novel insights into cancer
research and related to therapy efficacy. However, it is
important to remember that the methods that have been
applied for portraying the tumor microenvironment have
only attained limited validation, and it is unclear how
reliable their estimations are. In this study, we took a step
back and focused on generating cell type gene scores that
could reliably estimate enrichment of cell types. Our
method, which is gene signature-based, is more reliable
due to its reliance on a group of signatures for each cell
type, learned from multiple data sources, which increases
the ability to distinguish the signal from the noise. Our
method also integrates a novel approach to remove
dependencies between cell types, which allows better
reliability when studying closely related cell types.
To develop xCell, we collected the most comprehen-
sive resource to date of primary cell types, spanning the
largest set of human cell types. We then performed an
extensive validation of the predicted cell type inferences
in mixed samples. Our method for choosing a set of sig-
natures that are reliable across several data sources has
proven to be beneficial, as our scores robustly outper-
formed all available methods in predicting the abun-
dance of cell types in in silico mixtures and blood
samples. Based on our evaluation, xCell provides the
most accurate and sensitive way to identify enrichment
of many cell types in an admixture, allowing the
detection of subtle differences in the enrichment of aparticular cell type in the tumor microenvironment with
high confidence.
It is important to note that xCell, as all other methods,
performed significantly better in simulated mixtures
than in real mixtures. Several technical reasons account
for this discrepancy. First, the cytometry analyses were
performed on PBMCs, while the gene expression profiles
were generated from whole blood. Second, not all genes
required by xCell were present; in fact, in SDY420 only
54.5% of the genes required by xCell were available.
However, other explanations for the lower success when
inferring abundances in real samples are possible—it
may well be possible that the expression patterns of
marker genes in mixtures are different to those in
purified cells. Recent technologies such as single-cell
RNA-sequencing may be able to clarify how much this
may perturb the analyses.
We chose to apply a gene signature enrichment ap-
proach over deconvolution methods because of several
advantages that the former provides. First, gene signa-
tures are rank-based and are therefore suitable for cross-
platform transcriptome measurements. We showed here
that our scores reliably predict enrichment when using
different RNA-seq techniques and different microarray
platforms. They are agnostic to normalization methods
or concerns related to batch effects, making them robust
to both technical and biological noise. Second, there is
no decline in performance with increasing numbers of
cell types. The tumor microenvironment is a rich milieu
of cell types, and our analyses show enrichment of many
cells derived from mesenchyme in tumors. A partial por-
trayal of the tumor microenvironment may result in
misleading findings. Finally, gene signatures are simple
and can easily be adjusted.
The main disadvantage of gene signatures is that they
do not discriminate between closely related cell types
well, though it is not clear how well other methods dis-
tinguish between such cell types [10]. Our method takes
this into account and uses a novel technique, inspired by
flow cytometry analyses, to remove such dependencies
between closely related cell types. It is important to note
that, until this step, the cell type scores are independent
of each other, and a false inference of one cell type will
not harm all other cell types. However, the spillover cor-
rection adjustment removes this strict independence be-
tween cell type inferences, as in deconvolution methods.
Yet, the compensation is very limited, and between most
cell types there is no compensation at all; thus, most of
the inferences are still independent.
Despite the utility of our signatures for characterizing
the tumor microenvironment, several issues require fur-
ther investigation. While our signatures outperformed
previous methods, it is important to note that our corre-
lations with direct measurements were still far from
Aran et al. Genome Biology  (2017) 18:220 Page 10 of 14perfect. More expression data from pure cell types, espe-
cially cell types with limited samples, and more expression
data coupled with cytometry counts from various tissue
types will allow more precise definition of signatures and,
in turn, better reliability. Meanwhile, it is necessary to
refer to inferences made by our method or other methods
with caution. Discoveries made using digital dissection
methods must be rigorously validated using other tech-
nologies to avoid hasty conclusions.
Another limitation of our method is that the inferences
are strictly enrichment scores, and cannot be interpreted
as proportions. This is due to the inability to translate the
minimum and maximum scores produced by ssGSEA to
clear proportions. Thus, while our method attempts to
calibrate the scores to resemble proportions, these cannot
be reliably used as such. This limitation also does not pro-
vide statistical significance for the inferences, by calculating
an empirical p value as suggested by Newman et al. [7].
Conclusions
Tissue dissection methods are an emerging tool for
large-scale characterization of tumor cellular heterogen-
eity. These approaches do not rely on tissue dissociation,
as opposed to single-cell techniques, and therefore pro-
vide an effective tool for dissecting solid tumors. The
great availability of public gene expression profiles al-
lows these methods to be efficiently performed on hun-
dreds of historical cohorts spanning thousands of
patients, and to associate them with clinical outcomes.
Here we present the most comprehensive collection of
gene expression enrichment scores for cell types. Our
methodology for generating cell type enrichment scores
and adjusting them to cell type proportions allowed us
to create a powerful tool that is the most reliable and ro-
bust tool currently available for identifying cell types
across data sources. We provide a simple web tool, xCell
(http://xCell.ucsf.edu/), to the community and hope that
further studies will utilize it for the discovery of novel
predictive and prognostic biomarkers, and new thera-
peutic targets.
Methods
Data sources
Signature data sources
RNA-seq and cap analysis gene expression (CAGE)
normalized FPKM values were downloaded from the
FANTOM5 [33], ENCODE [34], and Blueprint data portals
[19]. Raw Affymetrix microarray CEL files were down-
loaded from the Gene Expression Omnibus (GEO), acces-
sions GSE22886 (IRIS) [35], GSE24759 (Novershtern) [36],
and GSE49910 (HPCA) [37], and analyzed using the Ro-
bust Multi-array Average (RMA) procedure on probe-level
data using Matlab functions. The analysis was performed
using custom CDF files downloaded from Brainarray [38].All samples were manually annotated to 64 cell types
(Additional file 1).
Other expression data sources
RNA-seq normalized counts were downloaded from the
GEO, accession GSE60424 [39]. Illumina HumanHT-
12 V4.0 Beadchip data of PBMC samples and the
accompanying CyTOF data were downloaded from
ImmPort accession SDY311 [40] and quantile normalized
using Matlab functions. Similarly, Agilent Whole Human
Genome 4 × 44 K slide data of PBMC samples and the
accompanying CyTOF data were downloaded from
ImmPort accession SDY420 [41] and quantile normalized
using Matlab functions. Multiple probes per gene were
collapsed using averages. RNA-seq data from the Cancer
Cell Line Encyclopedia (CCLE) was obtained using the
PharmacoGx R package [42]. RSEM levels for 9947 pri-
mary tumor samples from TCGA and TARGET were
downloaded from https://toil.xenahubs.net. Published sig-
natures were collected from their corresponding papers
[6, 12, 27, 28] (Additional file 5).
In silico simulated mixtures
We generated several types of simulated mixtures, but
all are based on the same pipeline:
1) Given a data source of pure cell types, choose n cell
types available in the data and choose a random
fraction for each cell type (the fractions sum to 1).
We denote this vector of fraction f.
2) Generate an expression matrix of pure cell types, M,
with n columns. The generation of the expression
matrix varied between the experiments we
performed: a) Synthetic mixtures for learning the
power coefficient and spillover matrix were
generated using the median expression profile of
each cell type, creating a homogenous and noiseless
mixture. b) Training mixtures were generated by
randomly choosing one of the multiple available
samples for each of the cell types chosen to be
included in the mixture. This random selection
introduces significant noise into the mixture, and
between mixtures in the mixture set, which reflects
the variation we observe in real datasets.
c) Test mixtures, where only one sample per cell
type was available, were generated by adding a
random noise for each gene of up to 20% of the
expression level. Cell types included in a mixture
were chosen randomly, by avoiding cell types that
cannot be distinguished (e.g., CD4+ T cells and
CD4+ memory T cells).
3) To generate a simulated expression profile we use the
formulaM × f, which returns one simulated mixed
gene expression profile based on additive expression
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process is then repeated 500 times with different f and
differentM (as explained in 2b and 2c,M is recreated
for each simulation by adding random noise (in b) or
choosing a random sample), generating distinct
mixtures using the same set of cell types.
The xCell development pipeline
A workflow of the xCell development pipeline can be found
in Additional file 2: Figure S1, and is described in detail below.
Filtering cancer genes
In a previous study [16] we calculated using CCLE the
number of cell lines that over-express each gene (twofold
more than the peak of expression distribution). For gener-
ating the signatures we only use genes that have an over-
expression rate of less than 5% (less than 32 cell lines of
the 634 carcinoma cell lines). We use this stringent
threshold to eliminate genes that tend to be overexpressed
in tumors, regardless of the cellular composition. Of
18,988 genes analyzed, 9506 were identified as not being
overexpressed in tumors. For signatures of cell types that
may be the cell of origin of solid tumors, including epithe-
lial cells, sebocytes, keratinocytes, hepatocytes, melano-
cytes, astrocytes, and neurons, we used all genes.
Generating gene signatures
Expression profiles were reduced to 10,808 genes that
are shared across all six data sources. Gene expression
was converted to log scale by adding 3 to restrict inclu-
sion of small changes and followed by log2 conversion.
In each group of samples corresponding to a cell type
we calculated 10th, 25th, 33.3th, and 50th percentiles of
low expression (Q1q), and 90th, 75th, 66.6th, and 50th
quantiles of high expression (Q21-q). For cell type A we
calculated the difference for each gene between Q1q(A)
and max(Q21-q(all other cell types)). We repeated this
also for second and third largest Q21-q(all other cell
types). The signature of cell type A consists of all genes
that pass a threshold. We used different thresholds here:
0, 0.1, log2(1.5), log(2), 3, 4, and 5. We repeated this pro-
cedure for each of the six data sources independently.
Only gene sets of at least eight genes and no more than
200 genes were reserved. This scheme yielded 6573 gene
signatures corresponding to 64 cell types. We calculated
single-sample gene set enrichment analysis (ssGSEA) for
each of those signatures to score each sample in each of
the data sources using the GSVA R package [43].
Choosing the “best” signature
For each signature we computed the t-statistic between
the scores of the corresponding cell type compared to all
other samples, omitting samples from parental or des-
cendant cell types (i. e. CD4+ naïve T cells the generalCD4+ T cells were not used in the calculations). The
procedure was performed for each data source where
the corresponding cell type was available, except the
data source from which the signature was learned. Thus,
a signature was only chosen if it is reliable in a data
source it was not trained upon. If the cell type was avail-
able in only one data source, the signature was tested in
that data source. From each data source the top three
signatures were chosen. All together we chose 489 signa-
tures corresponding to 64 cell types (across the six data
sources we have 163 cell types; Additional file 3). The
raw score for a cell type is the average of all correspond-
ing signatures, after shifting scores of each signature to
have a minimal score of 0 across all samples.
Learning parameters for raw score transformation
For each cell type we created a synthetic mixture using
the median expression profile of the cell type (cell X) and
an additional “control” cell type. For the control in
sequencing-based data sources we used multipotent pro-
genitor (MPP) cell samples or endothelial cell samples, be-
cause both are found in all the sequencing-based data sets.
In microarray-based data sources we used erythrocytes
and monocytes. We generated such mixtures using in-
creasing levels of the corresponding cell type (0.8% of cell
X and 99.2% control, 1.6% cell X and 98.4% control, etc.).
We noticed two problems with the raw scores: ssGSEA
scores have different distributions between different signa-
tures and a score from signatures cannot thus be com-
pared with a score from another signature. In addition, in
sequencing-based data, the association between the under-
lying levels of the cell type was not linearly associated with
the score. We thus designed a transformation pipeline for
the scores (which is applied to both sequencing and
microarray-based datasets separately)—for each cell type,
using the synthetic mixtures, we first shifted the scores to
0 using the minimal score (which corresponded to mix-
tures containing 0.8% of the cell type) and divided by
5000. We then fit a power function to the scores corre-
sponding to abundances of 0.8 to 25.6%. We used this
range because we are mostly interested in identifying cell
types with low abundance, and above that the function ex-
ponential increase may interfere with precise fitting. The
power coefficient was then averaged across the data
sources were the cell type is available (we denote this vec-
tor as P). After adjusting the score using the learned
power coefficient, we fit a linear curve, and used the
learned slope as a calibration parameter for the adjusted
scores (denoted as V1).
Learning the spillover compensation reference matrix
Another limitation that was observed in the mixtures is
the dependencies between closely related cell types:
scores that predict enrichment of one cell type also
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not even be in the mixture. To overcome this problem
we created a reference matrix of “spillovers” between cell
types. Below we focus on the generation of the
sequencing-based spillover matrix but an equivalent
process was performed to generate the microarray-based
spillover matrix. We first generated a synthetic mixture
set, where each mixture contains 25% of each of the cell
types (median expression) and 75% of a “control” cell
type, as in the previous section. We then calculated raw
cell type scores and transformed them using the
learned coefficients as explained above. We combined
all sequencing-based data sources together by using the
average scores, and completed the matrix to be 64 × 64
by adding columns from cell types that are not present
in any of the sequencing-based data using the micro-
array reference matrix. We then normalized each row
of cell type scores by dividing it by the diagonal (de-
noted as K; in the spillover matrix rows are cell type
scores and columns are cell type samples). The diag-
onal, before the normalization, is also used for cali-
bration (denoted as V2). The “spillover” between a
cell type score (x) and another cell type (y) is the ra-
tio between x and y. Finally, we cleaned the spillover
matrix to not compensate between parent and des-
cendent cell types by compensating parent cell types
only with other parent cell types (CD4+ T cells are
compensated against CD8+ T cells, but not CD8+
Tem), and compensating child cell types only com-
pared to other child cell types from the same parent
and all other parents, but not child cell types from
other parents. Some of the compensations were too
strong, removing correlations between cell types and
their corresponding signatures; thus, we limited the
compensation levels, off the diagonal, to 0.5. The
spillover matrix, power, and calibration coefficients
are available in Additional file 7.
Calculating scores for a mixture
The input comprises a gene expression data set normal-
ized to gene length (such as FPKM or TPM), where rows
are genes and columns are samples (N is the number of
samples). Duplicate gene names are combined to-
gether. xCell uses a set of 10,808 genes for the scor-
ing. It is recommended to use data sets that contain
at least the majority of these genes. Missing values in
a sample are treated as missing genes (the xCell web
tool requires intersection of at least 5000 genes). It is
also recommended to use as many samples as pos-
sible, with highly expected variation in cell type frac-
tions. (1) ssGSEA scores are calculated for each of
the 489 gene signatures. (2) Scores of all signatures
corresponding to a cell type are averaged. The result
is a matrix (A) with 64 rows and N columns. (3) Eachelement in the scores matrix (Aij) is transformed
using the following formula:
Tij ¼
Aij−min Aið Þð Þ=5000Pi
,
ðV1i⋅V2iÞ
The output is matrix T of transformed scores. Different
P, V1, and V2 are used for sequencing-based and
microarray-based datasets. (4) Spillover compensation is
then performed for each row using linear least squares
that minimizes the following (as performed in flow cytom-
etry analyses and explained in Bagwell and Adams [25]):
K ⋅x−Tik k; such thatx≥0
All x values are then combined to create the final xCell
scores. The compensation may result in deteriorating
real associations; thus, we provide a scaling parameter
(alpha) to multiply all off-diagonal cells in matrix K. In
all experiments in this study we used alpha = 0.5. Differ-
ent K matrices are used for sequencing-based and array-
based data.
Significance assessment
We provide a statistical significance assessment for the
presence of a cell type in the mixture by learning scores
distributions for cell types in random mixtures. For each
cell type X, we generate a random matrix as follows: In
each reference data set we find all cell types correspond-
ing to samples, except X and its parent or descendants
(if X is CD8+ Tem cells, then we also exclude CD8+ T
cells; if X is CD8+ T cells, we exclude all CD8+ cell
types). We then use the same procedure we used for
generating training samples, but adding an additional 5%
random noise. The main difference here is that we
randomly mix in all cell types (except X) and not just a
small subset. We then run the xCell pipeline for these
random mixtures. In most cell types the produced scores
show similarity to a beta distribution; thus, using the
fitdistr function from the MASS package, we fit such a
distribution for each of the mixtures we generated (e.g.,
for a mixture excluding cell type X we fit a beta distribu-
tion for cell type X). In five of the cell types the scores
from the random mixtures consistently produced 0;
thus, we define those distributions as constant 0.001
(Additional file 2: Figure S7). Given an input data set, we
can now calculate a p value for each xCell score with the
null hypothesis that the cell type is not present in the mix-
ture. The actual distributions we use to calculate the p
values are combinations of those learned from FAN-
TOM5, Blueprint, and ENCODE for sequencing-based
input, and IRIS, HPCA, and Novershtern for microarray-
based input. The p value for a score of a cell type in a sam-
ple is the chance of the region in the distribution of the
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samples we used a threshold of 20% to define a non-
significant score. We used this threshold to have a trade-
off between detecting the non-negligible scores of cell
types not in the mixture and not detecting scores of cell
type in the mixture, thus affecting the power of estimating
the underlying cell type fractions (Additional file 4).
Cytometry analyses
Gene expression and cytometry data were downloaded
from ImmPort (SDY311 [40] and SDY420 [41]). The
gene expression data were quantile normalized using
Matlab functions, and multiple probes per gene were
collapsed using averages. The cytometry data counts
were divided by the viable/singlet counts. In the SDY311
dataset, ten patients had two replicates of expression
profiles, and those were averaged. Two outlier samples
in the cytometry data set were removed from further
analyses (SUB134240, SUB134283).
Other tools
The CIBERSORT web tool was used for inferring pro-
portions using the expression profile (https://cibersort.
stanford.edu). CIBERSORT results for activated and
resting cell types were combined; B cell and CD4+ T
cell percentages are the combination of all their sub-
types. t-SNE plots were produced using the Rtsne R
package. Purity measurements were obtained from our
previous publication [31]. Correlation plots were gener-
ated using the corrplot R package.
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